跳至主要内容
临床试验/EUCTR2012-000513-36-IT
EUCTR2012-000513-36-IT进行中(未招募)不适用

Validation of the use of lymphography with green indocyanine in identifying the sentinel node in breast cancer

A.U.S.L. RIMINI0 个研究点开始时间: 2012年3月29日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Histologically or cytologically confirmed diagnosis of breast cancer
  • Early Breast cancer than or equal to 3 cm in diameter;
  • Clinically negative axilla;
  • Signature of Informed Consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hypersensitivity / allergy known to ICG, sodium iodide or iodine;
  • hyperthyroidism;
  • Thyroid cancer;
  • Patients who are pregnant and / or lactation;
  • Patients who are taking medicines that affect liver function;
  • Patients with renal insufficiency;
  • Patients who are taking drugs that may alter the absorption of green indocyanine
  • Patients with psychiatric illness or any illness that would impair the ability to provide informed consent for participation in this study.

研究者

发起方
A.U.S.L. RIMINI

相似试验